Plasmid encoding antiangiogenic metargidin peptide
Term · Oncology and biomedicine · MLC-T-ONC-016106
A plasmid encoding the protein antiangiogenic metargidin plasmid (AMEP), the disintegrin domain of ADAM-15 (metargidin), with potential antiangiogenic and antimetastatic activities. Upon intratumoral electrotransfer of plasmid encoding AMEP, AMEP binds to cellular integrin receptors alpha-v-beta-3 (avb3) and alpha-5-beta-1 (a5b1), which are upregulated on activated endothelial cells and a variety of tumor cells. Binding to the integrin receptors may inhibit angiogenesis and may inhibit tumor cell proliferation.
| Identifier | MLC-T-ONC-016106 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | peptide AMEP |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016106",
"term": "Plasmid encoding antiangiogenic metargidin peptide",
"field": "Oncology and biomedicine",
"definition": "A plasmid encoding the protein antiangiogenic metargidin plasmid (AMEP), the disintegrin domain of ADAM-15 (metargidin), with potential antiangiogenic and antimetastatic activities. Upon intratumoral electrotransfer of plasmid encoding AMEP, AMEP binds to cellular integrin receptors alpha-v-beta-3 (avb3) and alpha-5-beta-1 (a5b1), which are upregulated on activated endothelial cells and a variety of tumor cells. Binding to the integrin receptors may inhibit angiogenesis and may inhibit tumor cell proliferation.",
"synonyms": [
"peptide AMEP"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/plasmid-encoding-antiangiogenic-metargidin-peptide/"
}
Record 13,321 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.